https://www.indianpharmapost.com/abbvie-to-acquire-gilgamesh-pharmaceuticals-bretisilocin-for-12-billion-176742025-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/lighthouse-receives-492-million-nia-grant-to-advance-phase-2-study-of-alzheimers-disease-176752025-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/argenx-reports-positive-phase-3-adapt-seron-results-of-vyvgart-in-achr-ab-seronegative-gmg-176762025-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-expands-repatha-indication-to-adults-at-risk-of-major-cardiovascular-events-from-uncontrolled-ldl-c-176772025-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/samsung-india-introduces-next-gen-mobile-ct-imaging-solutions-176782025-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/thermo-fisher-opens-pipette-manufacturing-site-in-north-carolina-176812025-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/gileads-yeytuo-approved-in-eu-for-hiv-prevention-176792025-08-28T00:00:00+05:30always0.9https://www.indianpharmapost.com/fda-approves-coya-therapeutics-trial-of-coya-302-for-als-176802025-08-28T00:00:00+05:30always0.9